Sr. Vice President
Formerly Chief Operating Officer with Tute Genomics, Mr. Olson brings a depth of experience to PierianDx leading the commercialization of emerging biotechnologies. Before Tute, Andy led the sales and marketing efforts of Signature Genomics, the first company to introduce the use of microarray technology to the field of clinical cytogenetics. His experience includes commercial roles with: Roche Diagnostics, GeneOhm Sciences, Thermo Fisher, and Great Basin Corporation. He obtained an MBA from the University of Houston and a BS in molecular biology from Brigham Young University.